- জেনেরিক নাম
- Megestrol Acetate
- শক্তি
- 160 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- The ACME Laboratories Ltd.
Megenox 160 Tablet Tablet
Megenox 160 Tablet সম্পর্কে
Megenox 160 Tablet হলো Megestrol Acetate-এর একটি ব্র্যান্ড, শক্তি ১৬০ mg, ট্যাবলেট আকারে। এই ব্র্যান্ডের প্রস্তুতকারক The ACME Laboratories Ltd। Megenox 160 Tablet-এর সাথে Megestrol Acetate-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Megestrol Acetate-এর ১২টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Apit 40 mg Tablet-এর, প্রতি ইউনিট ৳ ৩৫.০০।
Megenox 160 Tablet কী?
The tablet Megenox 160 Tablet contains Megestrol Acetate and is made by The ACME Laboratories Ltd. It is not a substitute for accepted treatments such as surgery, radiation, or chemotherapy. Megenox 160 Tablet 160 mg tablet is a prescription medicine containing Megestrol Acetate, a synthetic progestational and antineoplastic drug. The doctor decides whether it is suitable and how long treatment should continue.
Megenox 160 Tablet-এর ব্যবহার
Palliative treatment aims to manage the disease when curative options are limited. It should not be used instead of accepted procedures such as surgery, radiation, or chemotherapy. Megenox 160 Tablet 160 mg tablet is used for palliative treatment of advanced breast cancer or endometrial cancer that is recurrent, inoperable, or metastatic. Ask your doctor whether it is right for your condition.
Megenox 160 Tablet কীভাবে ব্যবহার করবেন
Megenox 160 Tablet 160 mg tablet is taken by mouth. Swallow the tablet with water. Do not change the dose or stop treatment on your own.
Megenox 160 Tablet-এর পার্শ্বপ্রতিক্রিয়া
Glucocorticoid effects have been reported with long-term use, including new-onset diabetes, worsening of existing diabetes, and Cushing's syndrome. Thromboembolic events, including thrombophlebitis and pulmonary embolism, have been reported and can be fatal in some cases. Weight gain is a frequent side effect and is linked with increased appetite. Tell your doctor if any side effect bothers you or does not go away. Your doctor will monitor you during treatment.
সতর্কতা ও নিরাপত্তা
It is not recommended during the first four months of pregnancy. Do not use Megenox 160 Tablet 160 mg tablet if you have had a hypersensitivity reaction to Megestrol Acetate or any ingredient, or if you are pregnant or may be pregnant. Because of possible harm to a newborn, breastfeeding should be discontinued during treatment. Keep out of reach of children.
সাধারণ প্রশ্ন
What is Megenox 160 Tablet used for?
Palliative treatment aims to manage the disease when curative options are limited. It should not be used instead of accepted procedures such as surgery, radiation, or chemotherapy.
How do I use Megenox 160 Tablet correctly?
Megenox 160 Tablet 160 mg tablet is taken by mouth. Swallow the tablet with water.
What are the side effects of Megenox 160 Tablet?
Glucocorticoid effects have been reported with long-term use, including new-onset diabetes, worsening of existing diabetes, and Cushing's syndrome. Thromboembolic events, including thrombophlebitis and pulmonary embolism, have been reported and can be fatal in some cases.
Who should be careful with Megenox 160 Tablet?
It is not recommended during the first four months of pregnancy. Do not use Megenox 160 Tablet 160 mg tablet if you have had a hypersensitivity reaction to Megestrol Acetate or any ingredient, or if you are pregnant or may be pregnant.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Megestrol Tablet is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e., recurrent, inoperable, or metastatic disease). It should not be used instead of currently accepted procedures such as surgery, radiation, or chemotherapy.Megestrol Oral Suspension ... Read moreMegestrol Tablet is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e., recurrent, inoperable, or metastatic disease). It should not be used instead of currently accepted procedures such as surgery, radiation, or chemotherapy.
Megestrol Oral Suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of Acquired Immunodeficiency Syndrome (AIDS) & cancer.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Megestrol Acetate is a synthetic, antineoplastic and progestational drug. While the precise mechanism by which Megestrol Acetate produces its antineoplastic effects against endometrial carcinoma is unknown at the present time, inhibition of pituitary gonadotrophin production and resultant decrease in estrogen secretion may be factors. The antineoplastic action of megestrol acetate on carcinoma of the breast is effected by modifying the action of other steroid hormones and by exerting a direct cytotoxic effect on tumor cells. In metastatic cancer, hormone receptors may be present in some tissues but not others. The receptor mechanism is a cyclic process whereby estrogen produced by the ovaries enters the target cell, forms a complex with cytoplasmic receptor and is transported into the cell nucleus. There it induces gene transcription and leads to the alteration of normal cell functions. Pharmacologic doses of megestrol acetate not only decrease the number of hormone-dependent human breast cancer cells but also are capable of modifying and abolishing the stimulatory effects of estrogen on these cells.Estimates of plasma levels of Megestrol Acetate are dependent on the measurement method used. Peak plasma concentrations occur 2 to 3 hours after a single oral dose 160 mg tablets. The plasma half-life of Megestrol Acetate is 33 to 38 hours. Approximately 66% of an administered dose is excreted in the urine and approximately 20% in the faeces.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Tablet:- Breast cancer: 160 mg/day
- Endometrial carcinoma: 40-320 mg/day in divided doses.
- At least 2 months of continuous treatment is considered an adequate period for determining the efficacy of Megestrol.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pharmacokinetic studies show that there are no significant alterations in pharmacokinetics parameters of Zidovudine or Rifabutin to warrant dosage adjustment when Megestrol Acetate is administered with these drugs. The effects of Zidovudine or Rifabutin on the pharmacokinetics of Megestrol Acetate were not studied.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
History of hypersensitivity to Megestrol Acetate or any component of the formulation. Known or suspected pregnancy.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Weight Gain: Weight gain is a frequent side effect of Megestrol Acetate. This gain has been associated with increased appetite and is not necessarily associated with fluid retention.Thromboembolic Phenomena: Thromboembolic phenomena including thrombophlebitis and pulmonary embolism (in some cases fatal) have been reported.
Glucocorticoid Effects: The glucocorticoid activity of Megestrol Acetate has not been fully evaluated. Clinical cases of new onset diabetes mellitus, exacerbation of preexisting diabetes mellitus, and overt Cushing’s syndrome have been reported in association with the chronic use of Megestrol Acetate. In addition, clinical cases of adrenal insufficiency have been observed in patients receiving or being withdrawn from chronic Megestrol Acetate therapy in the stressed and non-stressed state.
Other: Nausea, dyspnea, tumor flare, hyperglycemia, glucose intolerance, alopecia, hypertension, carpal tunnel syndrome, mood changes, hot flashes, malaise, asthenia, lethargy, sweating and rash.
গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category D. The use of progestational agents during the first four months of pregnancy is not recommended. Very small amounts (approximately 0.1%) are excreted in mother's milk. It is however, not known whether these amounts exert any harmful effect on the newborn. Because of the potential for adverse effects on the new born, nursing should be discontinued during treatment with Megestrol Acetate.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
General: Close surveillance is indicated for any patient treated for recurrent or metastatic cancer. Use with caution in patients with a history of thromboembolic disease.Use in Diabetics: Exacerbation of preexisting diabetes with increased insulin requirements has been reported in association with the use of Megestrol Acetate.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
No serious unexpected side effects have resulted from studies involving Megestrol Acetate administered in dosages as high as 1600 mg/day.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store at or below 25°C. Protect from heat, light & moisture.বিকল্প ব্র্যান্ড: Megestrol Acetate
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।